Ranked India-based API manufacturers
01 India
Makes the APIFinished dose
Credentials confirmed against the regulator files on 25 July 2026
Holds 2 active US DMFs and 2 valid CEPs for clarithromycin, filing since 2003. Its 2020 FDA inspection closed as NAI, and its GMP is recognised in 15 markets.
Last FDA inspection
2020 · NAI
GMP recognised in
15 markets
02 India
Makes the APIFinished dose
Credentials confirmed against the regulator files on 25 July 2026
Holds one active US DMF and 2 valid CEPs for clarithromycin, filing since 2006. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 18 markets.
Last FDA inspection
2025 · VAI
GMP recognised in
18 markets
Credentials confirmed against the regulator files on 25 July 2026
Holds one active US DMF for clarithromycin, filing since 2020. Its 2023 FDA inspection closed as NAI, and its GMP is recognised in 3 markets.
Last FDA inspection
2023 · NAI
GMP recognised in
3 markets
Holds one active US DMF for clarithromycin, filing since 2013. Its GMP is recognised in 1 market.
Last FDA inspection
Not established
GMP recognised in
1 markets
05 India
Makes the APIFinished dose
Registered with SFDA (Saudi Arabia) for clarithromycin. Its GMP is recognised in 3 markets.
Last FDA inspection
Not established
GMP recognised in
3 markets
How this listing is sourced Regulator filings, warehouse snapshot 9 July 2026
View profile 3 more manufacturers in India hold filings for clarithromycin
The names are listed below. The filings, inspection history and GMP certificates behind
each one are available with a free account.
Open the full list with a free account How this list is built
This page filters the worldwide Clarithromycin manufacturer list to
companies based in India. The order is set by active filings weighted by regulator,
inspection outcomes and their recency, breadth of GMP recognition, and evidence of real
exports, less any open risk flags.
Read the full method.